← Open Payments lookup

MATTHEW VINNACOMBE: Open Payments

NPI 1053780981 · MOOSIC, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$898 in 62 payments from 14 companies in 2025. Trend: 2023 $1,626 · 2024 $1,787 · 2025 $898

Food & beverage: $898
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$195
ABBVIE INC.16$176
E.R. Squibb & Sons, L.L.C.11$146
Takeda Pharmaceuticals U.S.A., Inc.6$90
Neurocrine BioSciences, Inc.3$50
Teva Pharmaceuticals USA, Inc.3$48
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36
Alkermes, Inc.2$33
Lundbeck LLC2$32
Almatica Pharma LLC2$29

Products named: REXULTI, VRAYLAR, COBENFY, TRINTELLIX, INGREZZA, CAPLYTA, UZEDY, ARISTADA.

Industry payments across PA — which companies pay providers there.